Skip to main content

Regions

HIMSS23
By HIMSS TV | 04:30 pm | March 06, 2023
Cleveland Clinic's director of shared medical appointments, Dr. Marianne Sumego, previews her HIMSS23 lecture highlighting how to convert from in-person to virtual shared medical appointments and the advantages for patients and providers.
HIMSS23
By HIMSS TV | 04:15 pm | March 06, 2023
Dr. Robert Murry, chief medical officer at NextGen Healthcare, explains how digital health technology enables providers to conduct street medicine and coordinate care for patients who are homeless.
By Emily Olsen | 01:33 pm | March 06, 2023
Transcarent will purchase 98point6's virtual care platform and care business. After the deal, 98point6 will focus on licensing its software to third-party providers.
By Jessica Hagen | 11:55 am | March 06, 2023
Dr. Amanda Purnell, director of data and analytics innovation at the VHA Innovation Ecosystem, discusses the Mission Daybreak Grand Challenge.
By Jessica Hagen | 11:12 am | March 06, 2023
In an exclusive interview, Varjo and machineMD discuss their partnership to develop Neos, a VR-powered eye-tracking tool that aims to help providers detect brain disorders.
By HIMSS TV | 07:00 am | March 06, 2023
Gabriel Seidman, the Ellison Institute's director of policy, explains the efforts in building a nationwide enterprise architecture for data in healthcare that includes public health, clinical and social determinants data.
HIMSS23
By HIMSS TV | 05:12 pm | March 03, 2023
J. Tod Fetherling, Huron managing director, surveys the panel he’ll present at HIMSS23 regarding models the panelists developed that can help predict lung cancer and how to translate analytics into patient communication.
HIMSS23
By HIMSS TV | 04:59 pm | March 03, 2023
Mary Kratz, EVP at the Interoperability Institute, previews the panel she is leading at HIMSS23 covering cross-sector challenges to pursuing interoperability and the best uses of open-source solutions.
By HIMSS TV | 01:00 pm | March 03, 2023
Epigenetic profiling creates opportunities for healthcare and the development of new drugs based on it, according to Mohamad Takwa, CEO of Epigenica, a Sweden-based company that focuses on the technology.
By Emily Olsen | 11:56 am | March 03, 2023
In a post on LinkedIn, Color CEO Othman Laraki said the company would focus on its core lines of business, including testing and telehealth infrastructure for government programs, and its prevention tools for employers and healthcare purchasers.